Comparing the different analysis groups, there was a statistically significant difference in FFS (Fig 1A) and OS (Appendix Fig A2A, online only). Patients with N0 disease had the best outcome, and ...
Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results